Robert Weisman

Soaring demand for high-priced weight loss drugs, known as GLP-1s, has worsened affordability issues.

Founder Johannes Fruehauf is turning over the CEO reins to Maggie O’Toole, who was employee No. 1 when LabCentral launched in 2013.

Amid the Trump administration’s cuts, the 79-year-old sees "a direct threat to the most popular government program that has ever existed."

The new 300-bed tower, built in partnership with Beth Israel Deaconess Medical Center, would reshape the delivery of cancer care in Massachusetts.

Baby boomers, doing what they’ve done since they were kids, are the beating heart of spring training.

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

The costs of blockbuster weight-loss drugs, projected to double again this year, will likely boost premiums for Blue Cross members.

Emergency responders in Ayer and other towns across north central Massachusetts are struggling to adapt to the absence of Nashoba Valley Medical Center.

Health care providers say that hesitation and outright resistance to vaccines have become disturbingly common even in Massachusetts, a state that was at the forefront of developing and distributing COVID shots.

The head of the Massachusetts Health & Hospital Association has navigated one crisis after another, from the COVID-19 pandemic to Steward’s collapse.